Press release distribution, EDGAR filing, XBRL, regulatory filings


Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout )--Ironwood Pharmaceuticals, Inc. today announced DUZALLO was approved by the U.S. Food and Drug Administration as a once-daily oral treatment f... )--The "Precision Farming/Agriculture Market Analysis By Offering , By Application Therapeutic Market Analysis By Disease Type And Segment Forecasts, 2016 - 2025 - Research and Markets )--The "Central Nervous System Therapeutic Market Analysis By Disease Type And Segment Forecasts, 2016 - 2025" report has been added to Research and Markets' offering.



from Biotech News